"Welcome to St. Mary Health Yardley, formerly known as Whalen & McElmoyle Family Medicine. Meet our team of primary care physicians and providers: Drs. Christina McAdams, William McElmoyle, and Anne Whalen; providers Michelle Hall, CRNP, Kathy McInerney, CRNP, and Colleen Silk, CRNP."

During the past decade, St. Mary Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St. Mary Medical Center" are "Atherosclerosis" (1 trials), "Carotid Artery Disease" (1 trials), "Carotid Stenosis" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "St. Mary Medical Center" in a lesser frequency.

Most popular intervention types in "St. Mary Medical Center" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carotid WALLSTENT Monorail Endoprosthesis" (1 trials), "FilterWire EZ™ Embolic Protection System" (1 trials), "FilterWire EZ™ System™" (1 trials), "ION™ Coronary Stent System" (1 trials) and "NexStent Carotid Stent System (Monorail Delivery System)" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Mary Medical Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "St. Mary Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in St. Mary Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Mary Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".